146
Participants
Start Date
December 1, 2025
Primary Completion Date
July 31, 2029
Study Completion Date
July 31, 2029
AADvac1
AADvac1 administration: subcutaneous injection.
Matching Placebo
Matching placebo administration: subcutaneous injection.
Collaborators (2)
National Institute on Aging (NIA)
NIH
Alzheimer's Therapeutic Research Institute
OTHER
University of Southern California
OTHER
Massachusetts General Hospital
OTHER
University of California, San Diego
OTHER
Alzheimer's Clinical Trials Consortium
OTHER
Axon Neuroscience SE
INDUSTRY
Adam Boxer
OTHER